Solventum (NYSE:SOLV) Coverage Initiated by Analysts at Jefferies Financial Group

Key Points

• Jefferies Financial Group initiated coverage on Solventum (NYSE:SOLV) with a "hold" rating and a price target of $80.00, indicating a potential upside of 12.29% from its previous close.
• In recent assessments, various analysts have shown mixed ratings for Solventum, with a consensus of "Hold" and an average price target of $85.11 based on reports from multiple institutions.
• Solventum's recent earnings report showed earnings per share (EPS) of $1.69, surpassing estimates, with a year-over-year revenue increase of 3.8%, reinforcing the company's positive outlook for FY 2025 earnings guidance.

Jefferies Financial Group started coverage on shares of Solventum (NYSE:SOLV - Get Free Report) in a report issued on Thursday, Marketbeat Ratings reports. The firm set a "hold" rating and a $80.00 price target on the stock. Jefferies Financial Group's target price indicates a potential upside of 7.88% from the company's previous close.

Several other equities analysts also recently commented on the stock. Piper Sandler reiterated an "overweight" rating and set a $94.00 price target (up from $87.00) on shares of Solventum in a report on Friday, August 8th. Morgan Stanley upgraded shares of Solventum from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $80.00 to $103.00 in a research note on Tuesday, July 15th. Wells Fargo & Company upped their target price on shares of Solventum from $75.00 to $79.00 and gave the stock an "equal weight" rating in a research note on Friday, August 8th. KeyCorp began coverage on shares of Solventum in a research report on Friday, June 6th. They issued a "sector weight" rating for the company. Finally, Wall Street Zen cut shares of Solventum from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, September 9th. Four investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Solventum currently has an average rating of "Hold" and a consensus target price of $85.44.

Solventum Price Performance

Shares of Solventum stock traded up $0.95 during trading hours on Thursday, reaching $74.16. The company's stock had a trading volume of 362,969 shares, compared to its average volume of 1,079,621. The firm has a 50 day moving average price of $73.03 and a 200-day moving average price of $72.46. Solventum has a one year low of $60.70 and a one year high of $85.92. The company has a debt-to-equity ratio of 2.14, a current ratio of 1.22 and a quick ratio of 0.86. The stock has a market cap of $12.86 billion, a P/E ratio of 34.33, a P/E/G ratio of 2.99 and a beta of 0.53.

Solventum (NYSE:SOLV - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.24. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The firm had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. During the same period in the previous year, the firm posted $1.56 EPS. The business's quarterly revenue was up 3.8% on a year-over-year basis. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. On average, analysts predict that Solventum will post 6.58 EPS for the current year.

Institutional Trading of Solventum

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SOLV. Rossby Financial LCC acquired a new stake in Solventum during the first quarter valued at $25,000. Strengthening Families & Communities LLC lifted its stake in shares of Solventum by 376.8% in the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock worth $25,000 after buying an additional 260 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Solventum in the second quarter worth about $28,000. Raiffeisen Bank International AG purchased a new position in shares of Solventum in the fourth quarter worth about $29,000. Finally, Barrett & Company Inc. lifted its stake in shares of Solventum by 206.2% in the second quarter. Barrett & Company Inc. now owns 398 shares of the company's stock worth $30,000 after buying an additional 268 shares in the last quarter.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.